Načítá se...
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer’s disease
Several potential disease-modifying drugs for Alzheimer’s disease (AD) have failed to show any effect on disease progression in clinical trials, conceivably because the AD subjects are already too advanced to derive clinical benefit from treatment and because diagnosis based on clinical criteria alo...
Uloženo v:
| Vydáno v: | Alzheimers Dement |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4386839/ https://ncbi.nlm.nih.gov/pubmed/24795085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2014.02.004 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|